分子评估能否改善头颈部癌前病变的分类？ - Suppr

Suppr

超能文献

Can molecular assessment improve classification of head and neck premalignancy?

作者信息

Mao L

出版信息

Clin Cancer Res. 2000 Feb;6(2):321-2.

PMID:10690505

Abstract

摘要

相似文献

Can molecular assessment improve classification of head and neck premalignancy?

Clin Cancer Res. 2000 Feb;6(2):321-2.

Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variants.

Mod Pathol. 2002 Mar;15(3):229-54. doi: 10.1038/modpathol.3880520.

[Loss of heterozygosity as a tool in the evaluation of cancer risk in premalignant lesions of the head and neck].

Bull Cancer. 2000 Jun;87(6):446.

Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.

Indian J Dent Res. 2011 May-Jun;22(3):365-6. doi: 10.4103/0970-9290.87053.

PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.

Histopathology. 2018 Jan;72(2):330-338. doi: 10.1111/his.13381. Epub 2017 Nov 3.

[Detection of TP53-mutations in brush biopsies from oral leukoplakias].

Mund Kiefer Gesichtschir. 2002 Nov;6(6):410-4. doi: 10.1007/s10006-002-0425-0. Epub 2002 Sep 13.

Head and neck cancer and precancer: can we use molecular genetics to make better predictions?

Ann R Coll Surg Engl. 1999 Jan;81(1):1-11.

Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.

Cancer Res. 1996 Aug 1;56(15):3530-3.

Advances in the diagnosis of oral premalignant and malignant lesions.

J Can Dent Assoc. 2002 Nov;68(10):617-21.

Multiple oral squamous epithelial lesions: are they genetically related?

Oncogene. 2001 Apr 26;20(18):2235-42. doi: 10.1038/sj.onc.1204311.

引用本文的文献

Molecular Analysis as a Guide to Determining the Extent and Pathophysiology of Perilesional Tissues in Oral Epithelial Dysplasias.

J Maxillofac Oral Surg. 2020 Sep;19(3):447-455. doi: 10.1007/s12663-019-01303-z. Epub 2019 Nov 11.

Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.

Clin Epigenetics. 2018 Apr 3;10:43. doi: 10.1186/s13148-018-0470-7. eCollection 2018.

[Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias].

Mund Kiefer Gesichtschir. 2007 Dec;11(6):317-26. doi: 10.1007/s10006-007-0086-0. Epub 2007 Nov 8.

Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.

J Clin Pathol. 2002 Feb;55(2):98-104. doi: 10.1136/jcp.55.2.98.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Can molecular assessment improve classification of head and neck premalignancy?

作者信息

Mao L

出版信息

Clin Cancer Res. 2000 Feb;6(2):321-2.

PMID:10690505

Abstract

摘要

相似文献

Can molecular assessment improve classification of head and neck premalignancy?

Clin Cancer Res. 2000 Feb;6(2):321-2.

Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variants.

Mod Pathol. 2002 Mar;15(3):229-54. doi: 10.1038/modpathol.3880520.

[Loss of heterozygosity as a tool in the evaluation of cancer risk in premalignant lesions of the head and neck].

Bull Cancer. 2000 Jun;87(6):446.

Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.

Indian J Dent Res. 2011 May-Jun;22(3):365-6. doi: 10.4103/0970-9290.87053.

PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.

Histopathology. 2018 Jan;72(2):330-338. doi: 10.1111/his.13381. Epub 2017 Nov 3.

[Detection of TP53-mutations in brush biopsies from oral leukoplakias].

Mund Kiefer Gesichtschir. 2002 Nov;6(6):410-4. doi: 10.1007/s10006-002-0425-0. Epub 2002 Sep 13.

Head and neck cancer and precancer: can we use molecular genetics to make better predictions?

Ann R Coll Surg Engl. 1999 Jan;81(1):1-11.

Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.

Cancer Res. 1996 Aug 1;56(15):3530-3.

Advances in the diagnosis of oral premalignant and malignant lesions.

J Can Dent Assoc. 2002 Nov;68(10):617-21.

Multiple oral squamous epithelial lesions: are they genetically related?

Oncogene. 2001 Apr 26;20(18):2235-42. doi: 10.1038/sj.onc.1204311.

引用本文的文献

Molecular Analysis as a Guide to Determining the Extent and Pathophysiology of Perilesional Tissues in Oral Epithelial Dysplasias.

J Maxillofac Oral Surg. 2020 Sep;19(3):447-455. doi: 10.1007/s12663-019-01303-z. Epub 2019 Nov 11.

Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.

Clin Epigenetics. 2018 Apr 3;10:43. doi: 10.1186/s13148-018-0470-7. eCollection 2018.

[Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias].

Mund Kiefer Gesichtschir. 2007 Dec;11(6):317-26. doi: 10.1007/s10006-007-0086-0. Epub 2007 Nov 8.

Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.

J Clin Pathol. 2002 Feb;55(2):98-104. doi: 10.1136/jcp.55.2.98.